Health
Researchers develop novel class of cancer immunotherapy – Drug Target Review
The scientists developed a therapy which uses nanobiologics to train the innate immune system to recognise and combat cancer cells.
Posted: 30 October 2020 | Hannah Balfour (Drug Target Review) | No comments yet
The scientists developed a therapy which uses nanobiologics to train the innate immune system to recognise and combat cancer cells.
Researchers have developed a new type of cancer immunotherapy that uses nanobiologics to train the immune system to eliminate tumour cells. Nanobiologics are tiny materials bioengineered from natural molecules.
The lead candidate, called MTP10-HDL, was developed and tested on murine models…
-
Business18 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
Business20 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
General9 hours agoVictorian school teacher charged with soliciting child abuse material
-
General17 hours agoPatients speak out after Brisbane doctor accused of ‘excessive’ pap smears, kissing woman on lips